Remus Pharmaceuticals Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22

Sales

29.04

20.48

Operating profit

9.27

4.81

Interest

0.10

0.03

Gross profit

10.83

5.63

EPS (Rs)

53.01

37.52

Other income

1.66

0.85

Stock adjustment

-0.85

1.08

Raw material

-

-

Power and fuel

-

-

Employee expenses

3.29

1.91

Excise

-

-

Admin and selling expenses

-

-

Research and development expenses

-

-

Expenses capitalised

-

-

Other expenses

17.33

12.67

Provisions made

-

-

Depreciation

0.42

0.09

Taxation

2.60

1.47

Net profit / loss

7.81

4.07

Extra ordinary item

-

-

Prior year adjustments

-

-

Equity capital

1.47

1.09

Equity dividend rate

-

-

Agg.of non-prom. shares (Lacs)

-

-

Agg.of non promotoholding (%)

-

-

OPM (%)

31.91

23.48

GPM (%)

35.28

26.41

NPM (%)

25.43

19.09